Swidar (sulfadoxine/pyrimethamine) tab 500/25mg swipha

Swidar is a medication that contains a combination of sulfadoxine and pyrimethamine. It is commonly used for the treatment and prevention of malaria caused by Plasmodium falciparum.

Indication:

Swidar tablets are indicated for the following:

• Treatment of uncomplicated malaria caused by Plasmodium falciparum in areas where the parasite is known to be resistant to other antimalarial agents.
• Prophylaxis of malaria in individuals traveling to regions where Plasmodium falciparum is resistant to other antimalarial drugs.

Dosage:

The dosage of Swidar tablets may vary depending on the individual's age, weight, and the severity of the malaria infection. It is important to follow the dosage instructions provided by your healthcare provider or as indicated on the medication label.

As a general guideline, the typical adult dosage for the treatment of malaria is usually a single dose of three tablets taken together. For malaria prophylaxis, the dosage may vary, and it is important to start taking the medication before entering the malaria-endemic area and continue for a specified period after leaving the area.

It is crucial to consult with a healthcare professional before taking Swidar tablets to determine the appropriate dosage and duration of treatment based on your specific circumstances.